e-cigarettes

Health By Usha Lee McFarling

National Academies report cites ‘urgent’ need to recruit more diverse participants for clinical trials

D.C. Diagnosis By Nicholas Florko

As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms

Pharmalot By Ed Silverman

Pharmalittle: FDA declines to approve old antidepressant for Covid; U.S.-China trade fight may derail WTO Covid patent waiver

First Opinion By Danielle Wenner and Gabriela Arguedas Ramírez

Omitting long Covid from pandemic messaging is harmful for public health

First Opinion By Joe Lieberman and Michelle McMurry-Heath

Russian aggression underscores the U.S.’s need for greater investment in medical countermeasures

Health By Rachel Cohrs

What happens when the government stops buying Covid-19 vaccines?

Hospitals By Tara Bannow

Life or death decisions and no feedback: New study highlights the value of patient tracking, especially in the ER

Pharmalot By Ed Silverman

Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program